Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-28 · accession 0001519749-22-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-01 | 2022-02-28 | MYGN | Hart Jayne B. | CHRO | M - OptEx | $23.98 | +10.5K | 169.4K | +7% | +$251.8K |
| DM | 2022-03-01 | 2022-02-28 | MYGN | Hart Jayne B. | CHRO | S - Sale+OE | $25.00 | -10.5K | 165.9K | -6% | -$262.5K |
| DM | 2022-03-01 | 2022-02-28 | MYGN | Hart Jayne B. | CHRO | M - OptEx | $0.00 | -10.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-28 | M | A | 7,000 | $23.98 | 172,878 | D | — | — | (F2) Represents shares of common stock received upon exercise of a stock option award. |
| 2 | Common | Common Stock | 2022-02-28 | S | D | 7,000 | $25.00 | 165,878 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-28 | M | A | 3,500 | $23.98 | 169,378 | D | — | — | (F2) Represents shares of common stock received upon exercise of a stock option award. |
| 4 | Common | Common Stock | 2022-02-28 | S | D | 3,500 | $25.00 | 165,878 | D | — | — | |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-02-28 | M | D | 7,000 | $0.00 | 0 | D | $23.98 · — to 2022-03-07 | 7,000 Common Stock | (F3) The shares subject to this option are fully vested and exercisable. |
| 6 | Derivative | Incentive Stock Option (right to buy) | 2022-02-28 | M | D | 3,500 | $0.00 | 0 | D | $23.98 · — to 2022-03-07 | 3,500 Common Stock | (F3) The shares subject to this option are fully vested and exercisable. |